ResearchPod Summary
Understanding the formation of the HIV-1 latent reservoir is critical for developing a cure. While antiretroviral therapy (ART) effectively suppresses viral replication, the virus persists in a latent state within resting CD4+ T cells. Researchers have long debated whether this reservoir is formed continuously throughout the course of untreated infection or if specific events trigger its establishment. This study aimed to determine the timing of reservoir formation by comparing the genetic sequences of replication-competent viruses recovered from patients on long-term ART to the viral sequences circulating in their blood prior to therapy.
The researchers analyzed longitudinal samples from nine HIV-positive women in the CAPRISA 002 cohort. These participants were enrolled during acute infection and followed through several years of untreated infection before starting ART. After an average of five years of suppressive therapy, the team used the quantitative viral outgrowth assay (QVOA) to isolate replication-competent viruses from resting CD4+ T cells. By sequencing these outgrowth viruses and comparing them to the historical, pre-ART plasma viral sequences, the team used phylogenetic analysis to estimate the time each virus entered the latent reservoir.
The study found that, on average, 71% of the unique, replication-competent viruses in the latent reservoir were most genetically similar to viruses circulating in the blood during the year immediately preceding the initiation of ART. This pattern suggests that the reservoir is not a simple cumulative record of infection but is instead heavily skewed toward viruses present at the time therapy begins. The authors propose that the dramatic immunological changes occurring at the start of ART—such as the recovery of CD4+ T cell counts and shifts in immune activation—may create a favorable environment for infected cells to transition into a long-lived, latent state.
These findings challenge the assumption that the latent reservoir is formed at a constant rate throughout untreated infection. By identifying the time of therapy initiation as a critical window for reservoir establishment, this research suggests that therapeutic interventions aimed at this specific period could potentially limit the size of the reservoir. Strategies that modulate the host immune environment or interfere with the survival of newly infected cells at the start of treatment might significantly improve the prospects for an HIV cure.
AI-generated third-party summary by ResearchPod. Not official content or an endorsement by the paper authors or affiliated organizations.